These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Management of hyperlipidemias: an update. Ranjan N Indian J Dermatol Venereol Leprol; 2009; 75(5):452-62. PubMed ID: 19736423 [TBL] [Abstract][Full Text] [Related]
7. HDL scavenger receptor class B type I and platelet function. Nofer JR; van Eck M Curr Opin Lipidol; 2011 Aug; 22(4):277-82. PubMed ID: 21537173 [TBL] [Abstract][Full Text] [Related]
8. [Genetic predisposition in multiple metabolic syndrome. Part 3. Metabolism of lipids, lipoproteins and apolipoproteins]. Sobra J; Ceska R Cas Lek Cesk; 1999 Mar; 138(5):136-41. PubMed ID: 10376396 [TBL] [Abstract][Full Text] [Related]
9. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. Fazio S; Linton MF Circulation; 2005 Jun; 111(25):3349-51. PubMed ID: 15983260 [No Abstract] [Full Text] [Related]
10. Regulation of lipid and lipoprotein metabolism by retinoids. Staels B J Am Acad Dermatol; 2001 Nov; 45(5):S158-67. PubMed ID: 11606948 [TBL] [Abstract][Full Text] [Related]
11. [Results and prospects of studying the pathogenesis of cardiovascular diseases]. Gerasimova EN Vopr Med Khim; 1976; 22(2):147-51. PubMed ID: 1025880 [No Abstract] [Full Text] [Related]
12. Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells. Karshovska E; Weber C Curr Opin Lipidol; 2012 Aug; 23(4):400-1. PubMed ID: 22801391 [No Abstract] [Full Text] [Related]
13. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Siegel-Axel D; Daub K; Seizer P; Lindemann S; Gawaz M Cardiovasc Res; 2008 Apr; 78(1):8-17. PubMed ID: 18218686 [TBL] [Abstract][Full Text] [Related]
15. Lipid disorders and their relevance to outcomes in chronic kidney disease. Vaziri ND; Norris K Blood Purif; 2011; 31(1-3):189-96. PubMed ID: 21228589 [TBL] [Abstract][Full Text] [Related]
16. Bibliography. Current world literature. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol; 2001 Oct; 12(5):561-75. PubMed ID: 11678085 [No Abstract] [Full Text] [Related]
18. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates. Dominiczak M Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712 [No Abstract] [Full Text] [Related]
19. Inflammation, lipid metabolism dysfunction, and hypertension: active research fields in atherosclerosis-related cardiovascular disease in China. Yin K; Tang C Sci China Life Sci; 2011 Oct; 54(10):976-9. PubMed ID: 22038011 [No Abstract] [Full Text] [Related]
20. Hyperlipidaemia and cardiovascular disease: oxidative damage and atherosclerosis. Le NA Curr Opin Lipidol; 2006 Feb; 17(1):92-4. PubMed ID: 16407721 [No Abstract] [Full Text] [Related] [Next] [New Search]